TrialJournal of clinical laboratory analysis2022

Inflammation-based prognostic scoring system for predicting the prognosis of advanced small cell lung cancer patients receiving anlotinib monotherapy.

Tian Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.